BackBioLife Sciences Overview

BioLife Sciences Total Assets

BioLife Sciences's total assets is $1K.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1040.00
↓ 99.67% YoYΔ $-316494.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioLife Sciences Total Assets History

Loading

BioLife Sciences vs. peers: Total Assets Comparison

Loading

BioLife Sciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioLife Sciences (BLFE) FAQ

As of the most recent data (February 2022), BLFE shows a total assets of $1K. That compares with $320K in the prior-year period — down 99.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLFE's total assets is now $1K (was $320K) — a 99.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioLife Sciences is outperforming or lagging.

Tracking BLFE's total assets over time shows whether BioLife Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1K That compares with $320K in the prior-year period — down 99.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has BioLife Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $1K) with ownership activity and broader fundamentals.